| Stephan L Pro, MD | |
|
6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 | |
| (785) 843-9125 | |
| Not Available |
| Full Name | Stephan L Pro |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 20 Years |
| Location | 6265 Rock Chalk Dr, Lawrence, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457507659 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawrence Memorial Hospital | Lawrence, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lawrence Physicians Llc | 1951623834 | 179 |
| Newman Memorial County Hospital | 5193638526 | 48 |
News Archive
Britain's Health Secretary John Reid today announced that genetic test results used to predict possible future illness will not be used to deny people insurance.
A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between the amount of viruses in infected people's bodies, called the viral load, and how fast the number of cases is increasing or decreasing.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.
› Verified 9 days ago
| Entity Name | Newman Memorial County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114085594 PECOS PAC ID: 5193638526 Enrollment ID: O20040309001044 |
News Archive
Britain's Health Secretary John Reid today announced that genetic test results used to predict possible future illness will not be used to deny people insurance.
A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between the amount of viruses in infected people's bodies, called the viral load, and how fast the number of cases is increasing or decreasing.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.
› Verified 9 days ago
| Entity Name | Lawrence Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346657590 PECOS PAC ID: 1951623834 Enrollment ID: O20141203002058 |
News Archive
Britain's Health Secretary John Reid today announced that genetic test results used to predict possible future illness will not be used to deny people insurance.
A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between the amount of viruses in infected people's bodies, called the viral load, and how fast the number of cases is increasing or decreasing.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephan L Pro, MD 6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 Ph: (785) 843-9125 | Stephan L Pro, MD 6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 Ph: (785) 843-9125 |
News Archive
Britain's Health Secretary John Reid today announced that genetic test results used to predict possible future illness will not be used to deny people insurance.
A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between the amount of viruses in infected people's bodies, called the viral load, and how fast the number of cases is increasing or decreasing.
Workflow automation technology provider, Clarifire, announced today two pilots of its new product CLARIFIRE HEALTH. The pilots, performed in partnership with one of the largest Florida healthcare providers, will test intake processes and associated workflow as well as a mobile app that will be used by nurse managers when rounding with patients. Both pilots are designed to standardize patient care and improve patient satisfaction, risk management, and compliance.
An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology annual meeting in New Orleans.
› Verified 9 days ago
Kenneth L Wertzberger, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 907 Arkansas, Lawrence, KS 66044 Phone: 785-842-0611 Fax: 785-842-7488 | |
Dr. James Huston, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 Phone: 785-843-9125 Fax: 785-843-3176 | |
Dr. John Donald Galligan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 Phone: 785-843-9125 Fax: 785-843-3176 | |
Richard G Wendt, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 Phone: 785-843-9125 Fax: 785-843-3176 | |
Douglass E Stull, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6265 Rock Chalk Dr, Suite 1500, Lawrence, KS 66049 Phone: 785-843-9125 Fax: 785-843-3176 | |
Jeffrey C Randall, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6265 Rock Chalk Dr Ste 1500, Lawrence, KS 66049 Phone: 785-843-9125 Fax: 785-505-5312 |